DARA GUTHRIE: Open Payments
NPI 1417683103 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 27 payments from 10 companies in 2025. Trend: 2023 $317 · 2024 $462 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 8 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $130 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Vifor Pharma, Inc. | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Travere Therapeutics, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $17 |
Products named: TARPEYO, Kerendia, FARXIGA, Veltassa, JARDIANCE, Fabhalta, TAVNEOS, JYNARQUE.
Industry payments across TX — which companies pay providers there.
